Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT02333526Unknown

Syndecan 1 as Biomarker for Inflammation

Role: lead

NCT02397993Unknown

Serum Parameter Prior and After EUS-guided Fine Needle Aspiration of the Pancreas

Role: lead

NCT02331836Not ApplicableCompleted

Endocuff-assisted Versus Cap-assisted Versus Standard Colonoscopy

Role: lead

NCT03469622Not ApplicableUnknown

EndoRings Colonoscopy for Adenoma Detection

Role: lead

NCT02346448Not ApplicableUnknown

Endoscopic Sphincterotomy vs. Balloon Dilation for Assessment of Pancreatitis

Role: lead

NCT02034929Not ApplicableCompleted

EndoCuff-assisted Versus Standard Colonoscopy for Adenoma Detection

Role: lead

All 6 trials loaded